XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Offering
Common Stock
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
Accumulated Deficit
Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2020 $ 82,170   $ 3   $ 243,830   $ (161,664) $ 1
Beginning Balance, Shares at Dec. 31, 2020     27,325,959          
Net loss (28,034)           (28,034)  
Issuance of common stock upon exercise of stock options $ 9       9      
Issuance of common stock upon exercise of stock options, Shares 2,501   2,501          
Issuance of common stock purchased through employee stock purchase plan $ 42       42      
Issuance of common stock purchased through employee stock purchase plan, Shares     11,253          
Vesting of restricted stock (81)       (81)      
Vesting of restricted stock, Shares     26,994          
Stock-based compensation 2,366       2,366      
Unrealized gain (loss) on short term investments (2)             (2)
Ending Balance at Dec. 31, 2021 56,470   $ 3   246,166   (189,698) (1)
Ending Balance, Shares at Dec. 31, 2021     27,366,707          
Net loss (36,838)           (36,838)  
Issuance of common stock, net of issuance costs   $ 1,114       $ 1,114    
Issuance of common stock net of issuance costs, Shares       181,553        
Issuance of common stock and pre-funded warrants in common stock offering, net of issuance costs 46,645       46,645      
Issuance of common stock and pre-funded warrants in common stock offering, net of issuance costs, Shares     6,620,000          
Issuance of common stock upon exercise of stock options $ 44       44      
Issuance of common stock upon exercise of stock options, Shares 11,756   11,756          
Issuance of common stock purchased through employee stock purchase plan $ 173       173      
Issuance of common stock purchased through employee stock purchase plan, Shares     45,938          
Vesting of restricted stock (54)       (54)      
Vesting of restricted stock, Shares     31,962          
Issuance of warrants 2,008       2,008      
Stock-based compensation 2,838       2,838      
Unrealized gain (loss) on short term investments 33             33
Ending Balance at Dec. 31, 2022 $ 72,433   $ 3   $ 298,934   $ (226,536) $ 32
Ending Balance, Shares at Dec. 31, 2022     34,257,916